Facultad de Medicina (FM)
Centro académico
Weizmann Institute of Science
Rejovot, IsraelPublicacións en colaboración con investigadores/as de Weizmann Institute of Science (8)
2023
-
APLF and long non-coding RNA NIHCOLE promote stable DNA synapsis in non-homologous end joining
Cell Reports, Vol. 42, Núm. 1
2022
-
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling
Nature Cancer, Vol. 3, Núm. 11, pp. 1336-1350
-
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling (Nature Cancer, (2022), 3, 11, (1336-1350), 10.1038/s43018-022-00447-1)
Nature Cancer
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood, Vol. 138, Núm. 17, pp. 1583-1589
2018
-
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
Nature Medicine, Vol. 24, Núm. 12, pp. 1867-1876
2017
-
Iron affects Ire1 clustering propensity and the amplitude of endoplasmic reticulum stress signaling
Journal of Cell Science, Vol. 130, Núm. 19, pp. 3222-3233
2008
-
Immunotherapy for neurological diseases
Clinical Immunology